Similar articles

• Aggregin: the platelet receptor mediating activation by ADP.

  Colman RW, Puri RN, Zhou FX, Colman RF. Colman RW, et al. Prog Clin Biol Res. 1988;283:263-77. Prog Clin Biol Res. 1988. PMID: 3211953 No abstract available.
• Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.

  Cusack NJ, Hourani SM. Cusack NJ, et al. Br J Pharmacol. 1982 May;76(1):221-7. doi: 10.1111/j.1476-5381.1982.tb09210.x. Br J Pharmacol. 1982. PMID: 6282375 Free PMC article.
• Characterisation of ADP receptors.

  Cusack NJ, Hourani SM, Welford LA. Cusack NJ, et al. Adv Exp Med Biol. 1985;192:29-39. doi: 10.1007/978-1-4615-9442-0_3. Adv Exp Med Biol. 1985. PMID: 3010670 Review. No abstract available.
• Blood cells: an historical account of the roles of purinergic signalling.

  Burnstock G. Burnstock G. Purinergic Signal. 2015 Dec;11(4):411-34. doi: 10.1007/s11302-015-9462-7. Epub 2015 Aug 11. Purinergic Signal. 2015. PMID: 26260710 Free PMC article. Review.
• [Platelet membrane glycoproteins and their role in the receptor activity of blood platelets].

  Pawłowska Z, Cierniewski C, Krzesłowska J, Koziołkiewicz W. Pawłowska Z, et al. Postepy Biochem. 1988;34(3):183-207. Postepy Biochem. 1988. PMID: 2855751 Review. Polish. No abstract available.